157 related articles for article (PubMed ID: 34650688)
1. Identification of FAM107A as a potential biomarker and therapeutic target for prostate carcinoma.
Ma YF; Li GD; Sun X; Li XX; Gao Y; Gao C; Cao KX; Yang GW; Yu MW; Wang XM
Am J Transl Res; 2021; 13(9):10163-10177. PubMed ID: 34650688
[TBL] [Abstract][Full Text] [Related]
2. Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications.
Ma Z; Cheng X; Yue T; Shangguan X; Xin Z; Zhang W; Pan J; Wang Q; Xue W
Cancer Med; 2021 Aug; 10(15):5358-5374. PubMed ID: 34128342
[TBL] [Abstract][Full Text] [Related]
3. Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.
Zhang D; Zhang M; Zhang Q; Zhao Z; Nie Y
Med Sci Monit; 2020 Jul; 26():e924543. PubMed ID: 32735556
[TBL] [Abstract][Full Text] [Related]
4. Gleason Score-related MT1L as biomarker for prognosis in prostate adenocarcinoma and contribute to tumor progression in vitro.
Liu L; Li Y; Tang S; Yang B; Zhang Q; Xiao R; Hou X; Liu C; Ma L
Int J Biol Markers; 2023 Jun; 38(2):114-123. PubMed ID: 37192745
[TBL] [Abstract][Full Text] [Related]
5. High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration.
Piao S; Zheng L; Zheng H; Zhou M; Feng Q; Zhou S; Ke M; Yang H; Wang X
J Immunol Res; 2022; 2022():2922832. PubMed ID: 35707002
[TBL] [Abstract][Full Text] [Related]
6. Nur77 Serves as a Potential Prognostic Biomarker That Correlates with Immune Infiltration and May Act as a Good Target for Prostate adenocarcinoma.
Hu QY; Liu J; Zhang XK; Yang WT; Tao YT; Chen C; Qian YH; Tang JS; Yao XS; Xu YH; Wang JH
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770929
[TBL] [Abstract][Full Text] [Related]
7. Identification of the Putative Tumor Suppressor Characteristics of FAM107A
Ou D; Zhang Z; Wu Z; Shen P; Huang Y; She S; She S; Lin ME
Front Oncol; 2022; 12():861281. PubMed ID: 35669436
[TBL] [Abstract][Full Text] [Related]
8. TREM2 as an independent predictor of poor prognosis promotes the migration via the PI3K/AKT axis in prostate cancer.
Gao HT; Yang Z; Sun H; Zhang Y; Wang Z; Liu WY; Wen HZ; Qu CB; Wang XL
Am J Transl Res; 2023; 15(2):779-798. PubMed ID: 36915769
[TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma.
Qiao S; Zhang W; Su Y; Jiang Y
Front Oncol; 2022; 12():1037535. PubMed ID: 36591519
[TBL] [Abstract][Full Text] [Related]
10. Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma.
Wen CY; Tsui KH; Chang CH; Chiu YH; Lin SA; Chu CY; Li CJ
J Oncol; 2022; 2022():9854788. PubMed ID: 35132321
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value and potential function of splicing events in prostate adenocarcinoma.
Huang ZG; He RQ; Mo ZN
Int J Oncol; 2018 Dec; 53(6):2473-2487. PubMed ID: 30221674
[TBL] [Abstract][Full Text] [Related]
12. FAM107A Inactivation Associated with Promoter Methylation Affects Prostate Cancer Progression through the FAK/PI3K/AKT Pathway.
Ke S; Liu Z; Wang Q; Zhai G; Shao H; Yu X; Guo J
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010909
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Signature and Therapeutic Value of Phagocytic Regulatory Factors in Prostate Adenocarcinoma (PRAD).
Xin S; Sun X; Jin L; Li W; Liu X; Zhou L; Ye L
Front Genet; 2022; 13():877278. PubMed ID: 35706452
[TBL] [Abstract][Full Text] [Related]
14. A Novel Overall Survival Prediction Signature Based on Comprehensive Research in Prostate Cancer Bone Metastases.
Hu K; Hu X; Duan Y; Li W; Qian J; Chen J
Front Med (Lausanne); 2022; 9():815541. PubMed ID: 35783639
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome Profiles Reveal a 12-Signature Metabolic Prediction Model and a Novel Role of Myo-Inositol Oxygenase in the Progression of Prostate Cancer.
Liu W; Xiang J; Wu X; Wei S; Huang H; Xiao Y; Zhai B; Wang T
Front Oncol; 2022; 12():899861. PubMed ID: 35669435
[TBL] [Abstract][Full Text] [Related]
16. Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer.
He T; Zhang Y; Li X; Liu C; Zhu G; Yin X; Zhang Z; Zhao K; Wang Z; Zhao P; Wang K
World J Surg Oncol; 2022 Jun; 20(1):174. PubMed ID: 35650630
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.
Wang D; Feng M; Ma X; Tao K; Wang G
Life Sci; 2021 Jul; 277():119398. PubMed ID: 33831429
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value and potential subtypes of immune activity scores in three major urological cancers.
Shi B; Qi J
J Cell Physiol; 2021 Apr; 236(4):2620-2630. PubMed ID: 32853461
[TBL] [Abstract][Full Text] [Related]
19. High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration.
Zhang Y; Ji Q; Wang J; Dong Y; Pang M; Fu S; Wei Y; Zhu Q
Front Genet; 2022; 13():1100787. PubMed ID: 36685823
[TBL] [Abstract][Full Text] [Related]
20. Single-cell and bulk RNA-sequencing reveals mitosis-involved gene HAUS1 is a promising indicator for predicting prognosis and immune responses in prostate adenocarcinoma (PRAD).
Liu S; Yu Y; Xu J; Wang Y; Li D
Cell Biol Int; 2024 May; ():. PubMed ID: 38818762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
